Online
Glenmark Pharma
BSE: 532296 | NSE: GLENMARK | ISIN: INE935A01035 | Pharmaceuticals
| Finished Products | --------------------------- in Rs. Cr. --------------------------- | Mar 2009 | |||
| Product Name | Unit | Installed Capacity |
Production Quantity |
Sales Quantity |
Sales Value |
| Tablets & Capsules | Numbers | 1,180,800,000 | 752,893,839.00 | 757,502,380.00 | 340.81 |
| Liquids (Oral) | Litres | 8,166,666 | 5,002,682.00 | 4,859,858.00 | 167.67 |
| Ointments | Kgs | 1,087,500 | 631,728.00 | 620,370.00 | 143.55 |
| Lotions | Litres | 626,250 | 511,193.00 | 697,124.00 | 82.10 |
| Others | - | NA | 343,864.00 | NA | 63.22 |
| Injectables | - | NA | 192,422.00 | 255,206.00 | 56.65 |
| Solids (Powders & Granules) | Kgs | 113,000 | 231,673.00 | 197,963.00 | 10.73 |
| Other Fiscal Benefits | - | NA | NA | NA | 7.62 |
| Commission | - | NA | NA | NA | 2.91 |
| Cardiac Diagnestic Services | - | NA | NA | NA | 1.44 |
| Bulk Drugs | - | NA | NA | NA | 0.00 |
| Total | 876.70 | ||||
 | |||||
| Source : Religare Technova | |||||
| |||||
